Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 1998;57:464-469; doi:10.1136/ard.57.8.464
Copyright © 1998 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 1998;57:464-469 ( August )

Extended reports

Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome Masahiro Izumi,a Katsumi Eguchi,b Hideki Nakamura,b Yukinori Takagi,a Yojiro Kawabe,b Takashi Nakamuraa

a Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry, Japan, b First Department of Internal Medicine, Nagasaki University School of Medicine, Japan

Correspondence to: Dr T Nakamura, Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Accepted for publication 26 June 1998

OBJECTIVE---To determine the efficacy of corticosteroid irrigation of the parotid gland in relieving salivary flow deficiency in patients with Sjögren's syndrome.
METHODS---The parotid glands of 31 patients with primary (24) or secondary (seven) Sjögren's syndrome were irrigated either with saline solution followed by corticosteroid solution, or with saline solution alone. Salivary function was assessed by Saxon test.
RESULTS---Corticosteroid irrigation significantly increased the salivary flow rate in patients with Sjögren's syndrome (p< 0.0001), with clinical improvement detectable 3.7 (2.4) weeks (mean (SD)) after initial corticosteroid irrigation. The extent of improvement in salivary function was reciprocal to the clinical severity of the disease, with patients at the early stages obtaining 1.20 (0.57) g net increase in salivary flow rate, and patients at the most advanced stages obtaining 0.20 (0.47) g net increase. Repeated corticosteroid irrigations did not evoke corticosteroid refractoriness of the salivary gland; similar levels of net increase in salivary flow rate were observed after the second to fourth challenge of the corticosteroid in these patients. The sustained period was 8.4 (3.5) months (mean (SD)).
CONCLUSION---These findings suggest the clinical usefulness of corticosteroid irrigation therapy in relieving xerostomia in patients with Sjögren's syndrome.

Keywords: Sjögren's syndrome; xerostomia; corticosteroids


© 1998 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Lodde, B M, Baum, B J, Tak, P P, Illei, G (2006). Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment. Ann Rheum Dis 65: 1406-1413 [Abstract] [Full Text]  
  • Ramos-Casals, M, Tzioufas, A G, Font, J (2005). Primary Sjogren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 64: 347-354 [Abstract] [Full Text]  
  • Takagi, Y, Kimura, Y, Nakamura, T (2004). Cevimeline gargle for the treatment of xerostomia in patients with Sjogren's syndrome. Ann Rheum Dis 63: 749-749 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs